Expert Consensus on the Diagnosis and Treatment of Malignant Pericardial Mesothelioma
Med Research · 2025
DOI: 10.1002/mdr2.70003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Med Research, 2025. Verfasst von Qing Ji und 39 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, China Primary Health Care Foundation, China Postdoctoral Science Foundation.
Abstract (Originalsprache)
Primary malignant pericardial mesothelioma (PMPM), a rare pericardium‐derived malignancy, urgently requires standardized diagnostic and therapeutic protocols. This consensus, established by the Chinese Alliance of Research for Mesothelioma (ChARM) through the integration of evidence‐based research and multicenter clinical expertise, addresses the following critical aspects: The disease is characterized by insidious progression and local invasiveness with the majority of cases diagnosed at advanced stages. Current multimodal therapeutic strategies include radical surgery, platinum‐based combination chemotherapy, and precision radiotherapy. The introduction of PD‐1/PD‐L1 inhibitors has extended median survival to up to 24 months. The consensus emphasizes the diagnostic utility of multimodal imaging combined with histopathological immunohistochemical analysis. Furthermore, a stratified prognostic model incorporating tumor biomarkers is proposed to standardize follow‐up surveillance protocols, ensuring a systematic monitoring of disease progression and therapeutic efficacy.
Förderung
- National Natural Science Foundation of China
- China Primary Health Care Foundation
- China Postdoctoral Science Foundation
Zitieren
APA
Ji, Q., Xu, C., Wang, Q., Wang, W., Guo, Z., Li, Z., Song, Z., Liu, A., Yu, J., Zhong, W., Wang, Z., Fang, W., Zhang, Y., Liu, J., Zhang, S., Cai, X., Liu, A., Zhan, P., Liu, H., …, & Guo, H. (2025). Expert Consensus on the Diagnosis and Treatment of Malignant Pericardial Mesothelioma. Med Research. https://doi.org/10.1002/mdr2.70003
Vancouver
Ji Q, Xu C, Wang Q, Wang W, Guo Z, Li Z, et al. Expert Consensus on the Diagnosis and Treatment of Malignant Pericardial Mesothelioma. Med Research. 2025. doi:10.1002/mdr2.70003
BibTeX
@article{Ji2025,
author = {Ji, Qing and Xu, Chunwei and Wang, Qian and Wang, Wenxian and Guo, Zhenying and Li, Ziming and Song, Zhengbo and Liu, Aijun and Yu, Jinpu and Zhong, Wenzhao and Wang, Zhijie and Fang, Wenfeng and Zhang, Yongchang and Liu, Jingjing and Zhang, Shirong and Cai, Xiuyu and Liu, Anwen and Zhan, Ping and Liu, Hongbing and Lv, Tangfeng and Miao, Liyun and Min, Lingfeng and Lin, Gen and Huang, Long and Chen, Yu and Yuan, Jingping and Jiang, Zhansheng and Wang, Feng and Pu, Xingxiang and Rao, Chuangzhou and Lv, Dongqing and Ji, Yinghua and Liang, Xianbin and Yu, Zongyang and Li, Xiaoyan and Tang, Chuanhao and Zhou, Chengzhi and Zhang, Junping and Ma, Xuelei and Guo, Hui},
title = {Expert Consensus on the Diagnosis and Treatment of Malignant Pericardial Mesothelioma},
journal = {Med Research},
year = {2025},
doi = {10.1002/mdr2.70003}
}
EUVIMED